Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$11.96 - $19.35 $402,394 - $651,030
-33,645 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$17.35 - $24.87 $309,784 - $444,053
-17,855 Reduced 34.67%
33,645 $606,000
Q1 2021

May 14, 2021

BUY
$10.43 - $17.8 $537,145 - $916,700
51,500 New
51,500 $739,000
Q3 2018

Nov 14, 2018

SELL
$20.96 - $30.77 $569,378 - $835,867
-27,165 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$16.13 - $26.99 $1.17 Million - $1.96 Million
-72,435 Reduced 72.73%
27,165 $674,000
Q1 2018

May 15, 2018

SELL
$13.55 - $21.3 $344,170 - $541,020
-25,400 Reduced 20.32%
99,600 $1.64 Million
Q3 2017

Nov 14, 2017

BUY
$11.94 - $14.29 $1.49 Million - $1.79 Million
125,000
125,000 $1.53 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $235M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Manatuck Hill Partners, LLC Portfolio

Follow Manatuck Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manatuck Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manatuck Hill Partners, LLC with notifications on news.